Effect on Postpartum Hemorrhage of Prophylactic Oxytocin (10 IU) by Injection by Community Health Officers in Ghana: A Community-Based, Cluster-Randomized Trial

PLoS Medicine

Volumn 10, Issue 10, 2013, Pages

  Stanton, Cynthia K ^a   Newton, Samuel ^b   Mullany, Luke C ^a   Cofie, Patience ^c   Tawiah Agyemang, Charlotte ^b   Adiibokah, Edward ^b   Amenga Etego, Seeba ^b   Darcy, Niamh ^d   Khan, Sadaf ^e   Armbruster, Deborah ^f   Gyapong, John ^g   Owusu Agyei, Seth ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b KINTAMPO HEALTH RESEARCH CENTRE   (Ghana)

^c PATH   (Ghana)

^d RTI INTERNATIONAL   (United States)

^e PATH   (United States)

^f UNITED STATES AGENCY FOR INTERNATIONAL DEVELOPMENT   (United States)

^g UNIVERSITY OF GHANA   (Ghana)

Author keywords

[No Author keywords available]

Indexed keywords

OXYTOCIN;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ADULT; ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEASIBILITY STUDY; FEMALE; GHANA; HEALTH AUXILIARY; HUMAN; MAJOR CLINICAL STUDY; POSTPARTUM HEMORRHAGE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

FEMALE; GHANA; HUMANS; OXYTOCIN; POSTPARTUM HEMORRHAGE; PREGNANCY;

EID: 84886616884     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001524     Document Type: Article

References (24)

1. Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PF, (2006) WHO analysis of causes of maternal death: a systematic review. Lancet 367: 1066-1074.
2. World Health Organization, United Nations Children's Fund, United Nations Fund for Population Activities, The World Bank (2012) Trends in maternal mortality: 1990-2010. Geneva.
3. United Nations Children's Fund (2000) State of the Word's Children. New York, UNICEF.
4. United Nations Children's Fund (2012) State of the World's Children. New York, UNICEF.
5. World Health Organization (2007) WHO recommendations for the prevention and treatment of postpartum haemorrhage. Geneva: Department of Reproductive Health, WHO.
6. World Health Organization (2010) Clarifying the WHO position on misoprostol use in the community to reduce maternal death. Geneva: Department of Reproductive Health, WHO.
7. World Health Organization (2012) WHO recommendations for the prevention and treatment of postpartum haemorrhage. Geneva: Department of Reproductive Health, WHO.
8. Cotter AN, Tolosa A, (2010) Prophylactic oxytocin for the third stage of labour. Cochrane Library.
9. World Health Organization (2012) WHO recommendations Optimizing health worker roles to increase access to key maternal and newborn health interventions through task shifting. Geneva: Department of Reproductive Health, WHO.
10. Derman RJ, Kodkany BS, Goudar SS, Geller SE, Naik VA, et al. (2006) Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: a randomised controlled trial. Lancet 368: 1248-1253.
11. Mobeen N, Durocher J, Zuberi N, Jahan N, Blum J, et al. (2011) Administration of misoprostol by trained traditional birth attendants to prevent postpartum haemorrhage in homebirths in Pakistan: a randomised placebo-controlled trial. BJOG 118: 353-361.
12. Hoj L, Cardoso P, Nielsen BB, Hvidman L, Nielsen J, et al. (2005) Effect of sublingual misoprostol on severe postpartum haemorrhage in a primary health centre in Guinea-Bissau: randomised double blind clinical trial. BMJ 331: 723.
13. World Health Organization (2000) Managing Complications of Pregnancy and Childbirth; A guide for midwives and doctors. Geneva: Department of Reproductive Health, WHO.
14. Hogerzeil HV WGJA, de Goeje MJ (1993) Stability of injectable oxytocics in tropical climates: Results of field surveys and simulation studies on ergometrine, methylergometrine and oxytocin. Geneva: World Health Organization Action Programme on Essential Drugs.
15. Patel A, Goudar SS, Geller SE, Kodkany BS, Edlavitch SA, et al. (2006) Drape estimation vs. visual assessment for estimating postpartum hemorrhage. Int J Gynaecol Obstet 93: 220-224.
16. Stanton CK, Newton S, Mullany LC, Cofie P, Agyemang CT, et al. (2012) Impact on postpartum hemorrhage of prophylactic administration of oxytocin 10 IU via Uniject by peripheral health care providers at home births: design of a community-based cluster-randomized trial. BMC Pregnancy Childbirth 12: 42.
17. Kirkwood BR, Hurt L, Amenga-Etego S, Tawiah C, Zandoh C, et al. (2010) Effect of vitamin A supplementation in women of reproductive age on maternal survival in Ghana (ObaapaVitA): a cluster-randomised, placebo-controlled trial. Lancet 375: 1640-1649.
18. ICF International (2013) Ghana Demographic and Health Surveys Final Country Reports, 1993-2008. Available: http://www.statcompiler.com/. Accessed 14 April 2013.
19. Tsu VMT, Nguyen Y, Luu H, (2006) Reducing postpartum hemorrhage in Vietnam: Assessing the effectiveness of active management of third-stage labor. J Obstet Gynaecol Res 32: 489-496.
20. Tsu VLH, Mai T, (2009) Does a novel prefilled injection device make postpartum oxytocin easier to administer? Results from midwives in Vietnam. Midwifery 25: 461-465.
21. Althabe FVA, Cafferata M, Gibbons L, Karolinski A, Armbruster D, Buekens P, Belizan J, (2011) Using Uniject to increase the use of prophylactic oxytocin for management of the third stage of labor in Latin America. Int J Gynaecol Obstet 114: 184-189.
22. Tsu VSA, Vaidya K, (2003) Oxytocin in prefilled Uniject injection devices for managing third-stage labor in Indonesia. Int J Gynaecol Obstet 83: 103-111.
23. Liang K, Zeger SL, (1986) Longitudinal data analysis using generalized linear models. Biometrika 73: 13-22.
24. United Nations Commission on Life-saving Commodities for Women and Children (2012) United Nations Commission on Life-savng Commodities for Women and Children; Commissioners' Report 2012. New York, United Nations Commission on Life-saving Commodies for Women and Children.